Wilson Sonsini Goodrich & Rosati has advised Kura Oncology on patent matters related to the launch of Caspian Therapeutics. Kura Oncology Inc (Nasdaq: KURA) a biopharmaceutical...
Kura Oncology Launches Caspian Therapeutics with $50 Million Financing for Diabetes Drug Development
FDA Grants Full Approval to KOMZIFTI for Treatment of Relapsed or Refractory NPM1-Mutated AML
Wilson Sonsini Goodrich & Rosati has advised Kura Oncology on patent and trademark matters related to the deal. Kura Oncology and Kyowa Kirin have announced that...
Kura Oncology’s Collaboration with Kyowa Kirin
Wilson Sonsini Goodrich & Rosati and Cooley advised Kura Oncology. Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision...


























